Dr Reddy's PAT up 45 per cent at Rs 485 cr in Q3
Dr Reddy's Laboratories Ltd registered a 45 per cent increase in its profit after tax for the quarter ended December 31 at Rs 485 crore against Rs 334 crore in the third quarter of FY18, a senior official of the city-based drug maker said Friday.
President, CFO and Global Head of HR of Dr Reddy's, Saumen Chakraborty told reporters here, consolidated revenues for the quarter under review was up by one per cent to Rs 3,850 crore.
It was Rs 3,806 crore in the same quarter last fiscal.
The growth was based on improved performance in emerging markets, improved cost efficiencies and also party due to the profit booked on the sale of one of their plants here, he said.
"It has been a good quarter. On profit the year on year growth is 45 per cent.
There was also profit we made out of the sale of our Jeedimetla plant," Chakraborty said in a press conference.
Though the company was able to book a health profit during the quarter, revenues from North America declined by eight per ...